SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-655218
Filing Date
2016-07-22
Accepted
2016-07-22 16:41:56
Documents
5
Period of Report
2016-08-29
Effectiveness Date
2016-07-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d155483ddef14a.htm DEF 14A 652443
2 GRAPHIC g155483g01m68.jpg GRAPHIC 31200
3 GRAPHIC g155483g08c20.jpg GRAPHIC 36896
4 GRAPHIC g155483pcpg001.jpg GRAPHIC 120039
5 GRAPHIC g155483pcpg002.jpg GRAPHIC 88683
  Complete submission text file 0001193125-16-655218.txt   1028165
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36183 | Film No.: 161780057
SIC: 2836 Biological Products, (No Diagnostic Substances)